Search bioRxiv⌕ Search

Biology subjects

Costello, C. M.

Publications and source records attributed to Costello, C. M..

2 recordsLinked to original sources

Harmful algal bloom species Microcystis aeruginosa releases thiamin antivitamins to suppress competitors

In environmental ecosystems, vitamin concentrations are often exceedingly low (1, 2) and auxotrophy, or reliance on exogenous vitamin or vitamin precursors, is widespread (3-5). We show here that the widespread harmful algal bloom (HAB) species Microcystis aeruginosa, threatening freshwater aquatic ecosystems globally, releases a complex mixture of thiamin antivitamins, including bacimethrin and methoxythiamin, which induce thiamin deficiency in the benign model green alga Chlamydomonas reinhardtii. Putative biosynthetic genes for bacimethrin were upregulated in M. aeruginosa when grown in co-culture resulting in greater production of bacimethrin. Bacimethrin, methoxythiamin, oxidized forms of thiamin and methoxythiamin, and a novel structural homolog of bacimethrin were all found at elevated levels in the co-culture exometabolome extracts and were all inhibitory to the growth of C. reinhardtii individually at very low concentrations and as a mixture in culture medium extracts. The thiamin-requiring mutant C. reinhardtii, CC-25, was much more sensitive to bacimethrin and methoxythiamin than the wildtype. Thiamin addition largely rescued the inhibitory effects of exposure to antivitamins in both the wildtype and mutant strain. Finally, we determined that bacimethrin is present in aquatic environments and is elevated during Microcystis blooms. Thus, allelopathic suppression of competitors, particularly those that are auxotrophic for thiamin, by M. aeruginosa via the production of antivitamins in environments where thiamin availability is low, could help this species to become dominant and form blooms.

microbiology↗

Targeting the Pregnane X Receptor Using Microbial Metabolite Mimicry

The human pregnane X receptor (PXR), a master regulator of drug metabolism, has important roles in intestinal homeostasis and abrogating inflammation. Existing PXR ligands have substantial off-target toxicity. Based on prior work that established microbial (indole) metabolites as PXR ligands, we proposed microbial metabolite mimicry as a novel strategy for drug discovery that allows to exploit previously unexplored parts of chemical space. Here we report functionalized indole-derivatives as first-in-class non-cytotoxic PXR agonists, as a proof-of-concept for microbial metabolite mimicry. The lead compound, FKK6, binds directly to PXR protein in solution, induces PXR specific target gene expression in, cells, human organoids, and mice. FKK6 significantly represses pro-inflammatory cytokine production cells and abrogates inflammation in mice expressing the human PXR gene. The development of FKK6 demonstrates for the first time that microbial metabolite mimicry is a viable strategy for drug discovery and opens the door to mine underexploited regions of chemical space.

biochemistry↗